- Published at
- by forbes.com
neutral
neutral
Can SYK Stock Plunge Below $300?
This new device addresses the ongoing nursing shortage by streamlining workflows and providing seamless access to critical people and information.
News for Stryker Corporation (SYK)
- Published at
- by gurufocus.com
positivepositiveMicrobot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year This Appointment Rep- Published at
- by manilatimes.net
positivepositive- Published at
- by seekingalpha.com
neutralneutralStryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)
Stryker Corporation (NYSE:SYK) Citi’s 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ETCompany ParticipantsPreston Wells -...- Published at
- by gurufocus.com
positivepositiveStryker Corporation (SYK) Enters New $3 Billion Revolving Credit Agreement
On February 25, 2025, Stryker Corporation (SYK) announced the execution of a new revolving credit agreement, replacing its previous agreement from October 26,- Published at
- by investing.com
positivepositiveStryker: Bargain Stock With a Good Dividend Yield?
Stocks Analysis by Antonio Ferlito covering: Stryker Corporation, Inari Medical Inc. Read Antonio Ferlito's latest article on Investing.com- Published at
- by gurufocus.com
positivepositiveStryker Corporation Is Modestly Overvalued Despite Consistent Long-Term Growth
Stryker Corporation (SYK) is one of the largest global medical device companies with a focus on MedSurg, Neurotechnology, and Orthopaedics markets. The company- Published at
- by zacks.com
neutralneutralThe Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic
AbbVie, Amgen, Stryker, Dexcom and Medtronic are included in this Analyst Blog.- Published at
- by gurufocus.com
mixedmixedCurtiss-Wright Reports Fourth Quarter and Full-year 2024 Financial Results; Issues Full-year 2025 Guidance Reflecting Higher Sales, Operating Margin Expansion and Double-digit EPS Growth
Curtiss-Wright Corporation (NYSE: CW) reports financial results for the fourth quarter and full-year ended December 31, 2024. Fourth Quarter 2024 Highlights:- Published at
- by manilatimes.net
mixedmixed- Published at
- by insidermonkey.com
mixedmixed- Published at
- by insidermonkey.com
positivepositiveIs Stryker Corporation (SYK) the Best Automation Stock to Buy According to Hedge Funds?
We recently published a list of 12 Best Automation Stocks To Buy According to Hedge Funds.- Published at
- by manilatimes.net
positivepositive- Published at
- by zacks.com
neutralneutralStryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business
SYK announces agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC.- Published at
- by benzinga.com
mixedmixedUS Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings - Banzai International (NASDAQ:BNZI), ASML Holding (NASDAQ:ASM
U.S. stock futures were mixed ahead of the crucial earnings from key U.S. technology companies and the Fed's expected pause on rate cuts.- Published at
- by seekingalpha.com
positivepositiveStryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript
Stryker Corporation (NYSE:SYK) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ETCompany ParticipantsKevin Lobo - Chairman, CEO &...- Published at
- by zacks.com
neutralneutralStryker (SYK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.- Published at
- by zacks.com
neutralneutralStryker (SYK) Q4 Earnings and Revenues Surpass Estimates
Stryker (SYK) delivered earnings and revenue surprises of 3.62% and 1.34%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by finance.yahoo.com
mixedmixed3 Reasons to Buy Medtronic Stock Like There's No Tomorrow
This medtech giant is leveraging the power of artificial intelligence for a strong growth outlook.- Published at
- by seekingalpha.com
positivepositiveStryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings? (NYSE:SYK)
Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term growth potential despite high valuations.